Hypersexuality associated with safinamide

Hypersexuality associated with safinamide

Bibliographic Details
Main Authors:	A. Puy-Núñez, I. Cabo-López
Format:	Article
Language:	English
Published:	Elsevier España 2020-09-01
Series:	Neurología (English Edition)
Online Access:	http://www.sciencedirect.com/science/article/pii/S2173580820301462

Similar Items

SURINPARK: Safinamide for Urinary Symptoms in Parkinson’s Disease
by: Ana Gómez-López, et al.
Published: (2021-01-01)

Hypersexual Disorder According to the Hypersexual Disorder Screening Inventory in Help-Seeking Swedish Men and Women With Self-Identified Hypersexual Behavior
by: Katarina Görts Öberg, PhD, et al.
Published: (2017-12-01)

The Role of Stress in Hypersexual Behavior
by: Gilliland, Randy
Published: (2015)

The role of emotional problems in hypersexuality
by: Marta García Barba, et al.
Published: (2020-06-01)

Enhancing the Solubility and Dissolution Performance of Safinamide Using Salts
by: Lei Gao, et al.
Published: (2020-10-01)

The resurgence of neurotransmitter modulation in Parkinson’s disease with safinamide
by: Müller T
Published: (2015-03-01)

Safinamide: an add-on treatment for managing Parkinson’s disease
by: Müller T
Published: (2018-04-01)

Pain Improvement in Parkinson’s Disease Patients Treated with Safinamide: Results from the SAFINONMOTOR Study
by: Diego Santos García, et al.
Published: (2021-08-01)

The Roles of Shame and Guilt in Hypersexual Behavior
by: Gilliland, Randy
Published: (2010)

Safinamide in Clinical Practice: A Spanish Multicenter Cohort Study
by: Gloria Martí-Andrés, et al.
Published: (2019-10-01)

The Current Evidence for the Use of Safinamide for the Treatment of Parkinson’s Disease
by: Abbruzzese G, et al.
Published: (2021-06-01)

Adjuvant therapies for Parkinson’s disease: critical evaluation of safinamide
by: Stocchi F, et al.
Published: (2016-02-01)

Safinamide Improves Non-Motor Symptoms Burden in Parkinson’s Disease: An Open-Label Prospective Study
by: Diego Santos García, et al.
Published: (2021-03-01)

A Spanish Consensus on the Use of Safinamide for Parkinson’s Disease in Clinical Practice
by: Javier Pagonabarraga, et al.
Published: (2020-03-01)

Emerging approaches in Parkinson’s disease – adjunctive role of safinamide
by: Müller T
Published: (2016-08-01)

Investigational agents in the treatment of Parkinson&#39;s disease: focus on safinamide
by: Malek NM, et al.
Published: (2012-08-01)

Prejudice Nation: Hypersexualization and Abuse in Jude Dibia’s
by: Chinenye Amonyeze, et al.
Published: (2021-07-01)

Hypersexuality in the Form of Porno Addiction: Clinical Observation
by: Garnik S. Коcharyan
Published: (2020-02-01)

A case of Klinefelter syndrome with hypersexual desire
by: Kingsley Okolie, et al.
Published: (2017-09-01)

Dementia Presenting with Hypersexuality: A Case Report
by: Prutha Desai, et al.
Published: (2015-01-01)

The negative consequences of hypersexuality: Revisiting the factor structure of the Hypersexual Behavior Consequences Scale and its correlates in a large, non-clinical sample
by: Mónika Koós, et al.
Published: (2021-06-01)

Hypersexuality in a Bangladeshi Female: A Case Report
by: S. M. Yasir Arafat, et al.
Published: (2020-01-01)

Diagnosis and treatment of participants of support groups for hypersexual disorder
by: Els Tierens, et al.
Published: (2014-09-01)

Retraction: Dementia Presenting with Hypersexuality: A Case Report
by: Prutha Desai, et al.
Published: (2016-01-01)

Hype and Hypersexuality: Kara Walker, Her Work and Controversy
by: Searles, Erikka Juliette
Published: (2006)

A Case of Hypersexuality in a Patient Receiving Aripiprazole for Schizophrenia
by: Lakshmi Priya, et al.
Published: (2021-01-01)

Hypersexual Behavior Following Craniocerebral Trauma– an Experience with Five Cases
by: Eghwrudjakpor PO, et al.
Published: (2008-01-01)

Neural substrates of sexual desire in individuals with problematic hypersexual behavior
by: Ji-Woo eSeok, et al.
Published: (2015-11-01)

Problematic hypersexuality: Findings among undergraduates in a Nigerian university
by: Abdullahi H
Published: (2017-01-01)

Development of a structure-validated hypersexuality scale in Chinese university students
by: Yanli Jia, et al.
Published: (2021-07-01)

Hypersexuality in neurological diseases: do we see only the tip of the iceberg?
by: Desiree Latella, et al.
Published: (2021-06-01)

Hypersexual Behaviors and Personality Traits in Men with Substance Use Disorders in Iran
by: Seyed Ghasem Seyed Hashemi
Published: (2020-01-01)

Successful use of transcranial magnetic stimulation in difficult to treat hypersexual disorder
by: Adarsh Tripathi, et al.
Published: (2016-01-01)

Hypersexuality, Gender, and Sexual Orientation: A Large-Scale Psychometric Survey Study
by: Bartók, R., et al.
Published: (2018)

Impact of SAfinamide on Depressive Symptoms in Parkinson’s Disease Patients (SADness-PD Study): A Multicenter Retrospective Study
by: Esteban Peña, et al.
Published: (2021-02-01)

Hipersexualidad en relación con safinamida
by: A. Puy-Núñez, et al.
Published: (2020-09-01)

Safinamide in the management of patients with Parkinson’s disease not stabilized on levodopa: a review of the current clinical evidence
by: Bette S, et al.
Published: (2018-09-01)

Are Sex Drive and Hypersexuality Associated with Pedophilic Interest and Child Sexual Abuse in a Male Community Sample?
by: Verena Klein, et al.
Published: (2015-01-01)

Association Between PTSD Symptom Clusters, Substance Use, Hypersexuality, and Erectile Dysfunction in Service Members and Veterans
by: Fruge, Jeremiah E.
Published: (2019)

Three Diagnoses for Problematic Hypersexuality; Which Criteria Predict Help-Seeking Behavior?
by: Piet van Tuijl, et al.
Published: (2020-09-01)